WallStreetZenWallStreetZen

NASDAQ: AUTL
Autolus Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Autolus Therapeutics revenue was $92.62M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $26.2M, up 7.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AUTL annual revenue was $75.4M, with 644.9% growth year-over-year.

AUTL past revenue growth

How has AUTL's revenue growth performed historically?

Company
927.9%
Industry
246.05%
Market
36.64%
AUTL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AUTL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AUTL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AUTL revenue history

Current Revenue
$92.6M
Current Earnings
-$289.0M
Current Profit Margin
-312%

Be the first to know when AUTL announces revenue.

AUTL Revenue History By Year

AUTL Yearly RevenueAUTL RevenueAUTL ChangeAUTL Revenue Growth
2025-12-31$75.39M$65.27M+644.94%
2024-12-31$10.12M$8.42M+496.00%
2023-12-31$1.70M-$4.66M-73.30%
2022-12-31$6.36M$4.03M+172.96%
2021-12-31$2.33M$615.00k+35.86%
2020-12-31$1.72M-$1.19M-41.02%
2019-12-31$2.91M$1.50M+106.68%
2018-09-30$1.41M-$286.00k-16.89%
2017-09-30$1.69M$481.00k+39.69%
2016-09-30$1.21MN/AN/A

1 of 1

Autolus Therapeutics Revenue FAQ

What was AUTL's revenue last quarter?

On Invalid Date, Autolus Therapeutics (NASDAQ: AUTL) reported Q1 2026 revenue of $26.22 million up 191.89% year over year. In the same quarter last year, Autolus Therapeutics's revenue was $8.98 million.

What was Autolus Therapeutics's revenue in 2025?

Autolus Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $75.39 million, a 644.94% increase year over year.

How much does Autolus Therapeutics make in a day?

Based on Autolus Therapeutics annual revenue for the past five years, AUTL makes an average of $52,545.75 per day.

What was Autolus Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Autolus Therapeutics's revenue has grown 927.9% year over year. This is 681.85 percentage points higher than the US Biotechnology industry revenue growth rate of 246.05%. Autolus Therapeutics's revenue in the past year totaled $92.62 million.

How much does Autolus Therapeutics make in a year?

Autolus Therapeutics's revenue by year for the past five years is:
  • Autolus Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $75.39 million, a 644.94% increase year over year.
  • Autolus Therapeutics's annual revenue for Dec 31, 2024 was $10.12 million, a 496% increase from 2023.
  • Autolus Therapeutics's annual revenue for 2023 was $1.70 million, a 73.3% decrease from 2022.
  • Autolus Therapeutics's annual revenue for 2022 was $6.36 million, a 172.96% increase from 2021.
  • Autolus Therapeutics's annual revenue for 2021 was $2.33 million, a 35.86% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.